US sodium citrate markets tightened through March 2026 as import availability remained constrained and upstream costs rose, lifting offers. In mid-March, transpacific freight costs accelerated and Chinese exporters lifted offers, while month-end buying to replenish thin pipelines reinforced the uptrend. Food-processing and pharmaceutical buyers shifted from cautious procurement to securing Apr-May supply, narrowing importers' leverage. Seasonal stability in beverage and processed-food volumes, with distributors restocking ahead of the Q2 dialysis cycle, supported demand even as West Coast shipments remained limited. Core sectors underpinned gains, with food processing driving the bulk of consumption for beverages and processed foods, encouraging buyers to accept higher offers for prompt-supply windows. Pharmaceutical and medical formulators maintained baseline purchases for electrolyte, anticoagulant and dialysis-flush applications while topping inventories. Outlook from ChemAnalyst points to further upward pressure in the near term, with projected changes in Apr, May, and Jun followed by a modest pullback and continued low-single-digit momentum into September, contingent on logistics and feedstock pricing.
